We are live on
!
Find out more
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
83 hedge funds and large institutions have $72.2M invested in TCR2 Therapeutics Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
70% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 37
Holders
83
Holding in Top 10
2
Calls
$1.94M
Puts
$605K
Top Buyers
| 1 | +$2.66M | |
| 2 | +$1.71M | |
| 3 | +$1.58M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$749K |
| 5 |
Millennium Management
New York
|
+$540K |
Top Sellers
| 1 | -$3.69M | |
| 2 | -$1.71M | |
| 3 | -$1.02M | |
| 4 |
Two Sigma Investments
New York
|
-$1.01M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$795K |